MyFinsight
Home
Blog
About
Proceeds from redemption
of short-term...
$10,948K
(-66.26%↓ Y/Y)
Proceeds from marketable
securities
$10,605K
(910.96%↑ Y/Y)
something is missing
$10,144K
Proceeds from
investments
$501K
(-89.11%↓ Y/Y)
Total net cash used in
investing activities
$4,310K
(113.80%↑ Y/Y)
Canceled cashflow
$27,888K
Decrease in cash and cash
equivalents
$2,043K
(105.29%↑ Y/Y)
Canceled cashflow
$2,267K
Investment in investment in
associate at fair value-...
$11,924K
Purchase of marketable
securities
$8,727K
Investment at fair value
$6,735K
(110.59%↑ Y/Y)
Purchase of
non-marketable securities
$500K
Purchase of property and
equipment
$2K
(-71.43%↓ Y/Y)
Net income
$78,156K
(1291.17%↑ Y/Y)
Deferred taxes
$31,633K
Stock-based compensation
$1,393K
(-53.40%↓ Y/Y)
Prepaid expenses and
other current assets
-$933K
(-14.34%↓ Y/Y)
Accounts payable,
accrued expenses and...
$882K
(126.89%↑ Y/Y)
Exchange differences and
interest on deposits
-$267K
(-465.75%↓ Y/Y)
Net changes in
operating lease
$39K
(-45.83%↓ Y/Y)
Depreciation
$31K
(-48.33%↓ Y/Y)
Liability for employee
rights upon retirement
$3K
(-50.00%↓ Y/Y)
Total net cash used in
financing activities
-$1,949K
(-425.34%↓ Y/Y)
Total net cash used in
operating activities
-$200K
(97.16%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$118K
(-402.56%↓ Y/Y)
Canceled cashflow
$113,337K
Tax withholdings
related to stock-based...
$1,871K
Dividend paid
$78K
Changes in fair value of
investments
$103,616K
(806.61%↑ Y/Y)
something is missing
-$9,836K
Deferred income
$82K
(135.19%↑ Y/Y)
Gain on amounts
funded in respect of...
$3K
(-50.00%↓ Y/Y)
Back
Back
Cash Flow
ORAMED PHARMACEUTICALS INC. (ORMP)
ORAMED PHARMACEUTICALS INC. (ORMP)
source: myfinsight.com